WBP4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.734170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.102800E-01
Normal-vs-Stage2
8.892200E-02
Normal-vs-Stage3
5.750000E-02
Normal-vs-Stage4
3.478800E-01
Stage1-vs-Stage2
1.537430E-01
Stage1-vs-Stage3
1.523200E-01
Stage1-vs-Stage4
6.847800E-01
Stage2-vs-Stage3
3.675800E-01
Stage2-vs-Stage4
5.462200E-01
Stage3-vs-Stage4
2.680000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.790980E-01
Normal-vs-AfricanAmerican
9.886300E-02
Normal-vs-Asian
1.426190E-01
Caucasian-vs-AfricanAmerican
6.591200E-01
Caucasian-vs-Asian
5.427000E-01
AfricanAmerican-vs-Asian
9.870600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.607580E-01
Normal-vs-Female
2.042000E-01
Male-vs-Female
4.361800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.203000E-01
Normal-vs-Age(41-60Yrs)
3.197600E-01
Normal-vs-Age(61-80Yrs)
1.358960E-01
Normal-vs-Age(81-100Yrs)
3.782200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.008600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.780200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.516160E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.998220E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.902770E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.862800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.840000E-03
Normal-vs-Daily Drinker
1.701920E-02
Normal-vs-Weekly Drinker
1.418350E-01
Normal-vs-Occasional Drinker
4.366200E-01
Normal-vs-Social Drinker
6.780800E-01
Non Drinker-vs-Daily Drinker
9.620400E-01
Non Drinker-vs-Weekly Drinker
4.955200E-01
Non Drinker-vs-Occasional Drinker
2.567600E-02
Non Drinker-vs-Social Drinker
5.881900E-02
Daily Drinker-vs-Weekly Drinker
5.657600E-01
Daily Drinker-vs-Occasional Drinker
2.748200E-02
Daily Drinker-vs-Social Drinker
6.661900E-02
Weekly Drinker-vs-Occasional Drinker
2.096200E-01
Weekly Drinker-vs-Social Drinker
2.015400E-01
Occasional Drinker-vs-Social Drinker
7.542200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.002300E-02
Normal-vs-Grade 2
1.301610E-02
Normal-vs-Grade 3
1.495980E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.777840E-01
Grade 1-vs-Grade 3
1.360980E-01
Grade 1-vs-Grade 4
9.002300E-02
Grade 2-vs-Grade 3
6.980000E-01
Grade 2-vs-Grade 4
1.301610E-02
Grade 3-vs-Grade 4
1.495980E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.186850E-01
Normal-vs-NonDiabetic
1.593630E-01
Diabetic-vs-NonDiabetic
2.740000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.018000E-01
Normal-vs-NoPancreatitis
1.533640E-01
Pancreatitis-vs-NoPancreatitis
6.702200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.137600E-01
Normal-vs-N1
9.878400E-02
N0-vs-N1
2.039800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.125990E-01
Normal-vs-TP53-NonMutant
4.621800E-01
TP53-Mutant-vs-TP53-NonMutant
1.004840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
